Surgical treatment of intrahepatic cholangiocarcinoma in the USA

Nir Lubezky, Marcelo Facciuto, Norifumi Harimoto, Myron E. Schwartz, Sander S. Florman

研究成果: Contribution to journalArticle

16 引用 (Scopus)

抜粋

Cholangiocarcinoma (CC) is a malignancy that arises from the epithelial cells of the biliary system (ductules as well as large ducts, and likely from progenitor cells, as well). Intrahepatic CC (ICC) is the second most common primary hepatic malignancy after hepatocellular carcinoma (HCC), and accounts for 10-15% of primary liver cancers. ICC differs from both extrahepatic and CC and HCC and has unique risk factors, histological features, genetic alterations and clinical outcomes. The natural history and results of surgical intervention are not well described as ICC is a relatively uncommon tumor, especially in the USA. This article reviews the literature relevant to the surgical management and outcome of patients with ICC in the USA.

元の言語英語
ページ(範囲)124-130
ページ数7
ジャーナルJournal of Hepato-Biliary-Pancreatic Sciences
22
発行部数2
DOI
出版物ステータス出版済み - 2 1 2015

All Science Journal Classification (ASJC) codes

  • Medicine(all)

フィンガープリント Surgical treatment of intrahepatic cholangiocarcinoma in the USA' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Lubezky, N., Facciuto, M., Harimoto, N., Schwartz, M. E., & Florman, S. S. (2015). Surgical treatment of intrahepatic cholangiocarcinoma in the USA. Journal of Hepato-Biliary-Pancreatic Sciences, 22(2), 124-130. https://doi.org/10.1002/jhbp.157